Results

1–10 of 12 results for syringe

Quality Assessment of a New Silicone-Free Syringe Developed for Intravitreal Injections
Gustavo Barreto de Melo, MD, PhD, FASRS
On Demand Cases, Courses, and Papers
2021
An Analysis of Particle Contamination and Protein Aggregation From Syringes Used for Intravitreal Injection
Jason Noble, MD, FRCSC
On Demand Cases, Courses, and Papers
2021
Treatment Switch From Aflibercept to Ranibizumab Pre-filled Syringe in Canadian DME Patients in a Real-World Setting: The PRECISE Study
Michel R Giunta, MD
On Demand Cases, Courses, and Papers
2021
Treatment Switch From Aflibercept to Ranibizumab Pre-filled Syringe in Canadian nAMD and DME Patients in a Real-World Setting: The PRECISE Study
Ananda Kalevar, MD, FRCS(C), DABO
On Demand Cases, Courses, and Papers
2020
Reduced Incidence of Post-Injection Endophthalmitis With Pre-filled Syringes
Daniel B. Roth, MD
On Demand Cases, Courses, and Papers
2020
Agitation of the Syringe as a Cause of Inflammation After Intravitreal Injection of Aflibercept: A Randomized, Double-blind, Controlled Clinical Trial
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2020
Particulate Matter From Syringes Used for Intravitreal Injections
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2020
Silicone Droplets are Released by Syringes and Found in the Vitreous
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2019
Endophthalmitis Rates of Prefilled Ranibizumab Syringes Compared to Conventional Ranibizumab Vials: An International Multicenter Study
Yoshihiro Yonekawa, MD, FASRS
Annual Meeting Talks
2018
Inflammation After Aflibercept Injection in Association With a Specific Brand of Syringe That Releases Silicone Oil Droplets A Case-Control Study
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2018